Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Agammaglobulinemia × Trimethoprim, Sulfamethoxazole Drug Combination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1

Conditions

Neoplasms, Plasma Cell 3 Neoplasms 3 Lymphoma 3 Leukemia 3 Infections 3 Lymphoma, Non-Hodgkin 1 Hematologic Neoplasms 1 Agammaglobulinemia 1

Interventions

plerixafor 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Immunoglobulins 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Clavulanic Acid 1 Ciprofloxacin 1 Amoxicillin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05678621 2024-04-19

RATIONALISE

Monash University

Phase 2/3 Recruiting

LymphoidOther hematologic neoplasmPlasma cell

Agammaglobulinemia, Infections, Leukemia, Lymphoma, Neoplasms, Hematologic Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡